High-Frequency Repetitive Transcranial Magnetic Stimulation over the Primary Foot Motor Area in Parkinson's Disease

References

Page 1

	Year	Citations
“Mini-mental state” Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh Journal of Psychiatric Research	1975	85.9K
Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996 Eric M. Wassermann Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section MedicineNeuromodulation TherapiesInternational WorkshopRehabilitationNeurology	1998	2.3K
Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex Álvaro Pascual‐Leone, Josep Valls‐Solé, Eric M. Wassermann, Brain Motor ControlStimulation DeviceKinesiologyNeurologyMotor Neurophysiology	1994	1.4K
Modulation of corticospinal excitability by repetitive transcranial magnetic stimulation Fumiko Maeda, Julian Paul Keenan, Josep M. Tormos, Clinical Neurophysiology Stimulation DeviceNeurophysiologyNeuroanatomyMedicineMotor Control	2000	730
A new self‐rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale Pär Svanborg, Marie Åsberg Acta Psychiatrica Scandinavica	1994	689
Cortical motor reorganization in akinetic patients with Parkinson's disease Umberto Sabatini, Kader Boulanouar, Nelly Fabre, Brain	2000	591
Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa Bernhard Haslinger, Peter Erhard, Nina Kämpfe, Brain	2001	486
Apathy following cerebrovascular lesions. Sergio Starkstein, J. Paul Fedoroff, T R Price, Stroke	1993	420
Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias Francesca Morgante, Alberto J. Espay, Carolyn Gunraj, Brain Motor DysfunctionNeurological DisorderMep AmplitudesLevodopa-induced DyskinesiasSocial Sciences	2006	317
Pharmacologically modulated fMRI---cortical responsiveness to levodopa in drug‐naive hemiparkinsonian patients Carsten Buhmann, Volkmar Glauche, Hans Jörg Stürenburg, Brain NeuropsychologyNeurological DisorderPsychotropic MedicationClinical NeurosciencePharmacotherapy	2003	308

Page 1